This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laperche, S. Articles by Simon, N. Search for Related Content PubMed PubMed Citation Articles by Laperche, S. Articles by Simon, N.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2005, p. 3877-3883, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.3877-3883.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection

National Reference Center for Hepatitis B and C in Transfusion, Institut National de la Transfusion Sanguine, Paris, France,¹ Etablissement Français du Sang Nord-de-France, Lille, France,² Etablissement Français du Sang Alpes-Méditerranée, Marseille, France,³ Etablissement Français du Sang Pyrénées-Méditerranée, Montpellier, France,⁴ Etablissement Français du Sang Bourgogne Franche-Comté, Dijon, France,⁵ Unité d'Hémodialyse Association pour l'Utilisation du Rein Artificiel, Paris, France⁶

Received 28 December 2004/ Returned for modification 9 March 2005/ Accepted 9 May 2005

To evaluate whether a new enzyme immunoassay developed for the simultaneous detection of hepatitis C virus (HCV) core antigen (Ag) and anti-HCV antibodies (anti-HCV Ab) (Monolisa HCV Ag/Ab ULTRA; Bio-Rad) could improve the early detection of HCV infection, we compared its sensitivity to that of anti-HCV, HCV core Ag, and HCV RNA assays. The populations studied included 12 blood donor samples positive for HCV RNA and HCV core Ag but negative for anti-HCV antibodies and 23 hemodialysis patients who developed anti-HCV Ab (seroconversion) during the follow-up. From these 23 individuals, 83 samples sequentially collected prior to seroconversion and 108 samples collected after seroconversion were tested. Six of 12 blood donations were positive by the HCV Ag/Ab assay. In the hemodialysis cohort, the 24 HCV RNA-negative samples were negative by the HCV Ag/Ab assay and 23 of the 59 HCV RNA-positive samples (39%) were positive. The HCV Ag/Ab assay detected HCV infection on average 21.6 days before the most sensitive antibody assay. The HCV Ag/Ab assay did not detect HCV infection as early as the HCV RNA assay (mean delay, 30.3 days) or HCV Ag assay (mean delays, 27.9, and 16.3 days by the HCV core Ag quantification assay and the HCV Ag blood screening assay, respectively). This new assay provides a notable improvement for the early detection of HCV infection during the so-called window period compared with anti-HCV Ab assays and could be a useful alternative to HCV RNA detection or HCV core Ag assays for diagnosis or blood screening when nucleic acid technologies or HCV core Ag detection are not implemented.

This article has been cited by other articles:

• Serra, A., Nuti, S., Tavarini, S., Sammicheli, C., Rosa, D., Saletti, G., Soldaini, E., Abrignani, S., Wack, A. (2008). Coligation of the Hepatitis C Virus Receptor CD81 with CD28 Primes Naive T Lymphocytes to Acquire Type 2 Effector Function. J. Immunol. 181: 174-185 [Abstract] [Full Text]  
• Quiroga, J. A., Castillo, I., Pardo, M., Rodriguez-Inigo, E., Carreno, V. (2006). Combined Hepatitis C Virus (HCV) Antigen-Antibody Detection Assay Does Not Improve Diagnosis for Seronegative Individuals with Occult HCV Infection. J. Clin. Microbiol. 44: 4559-4560 [Abstract] [Full Text]  
• Schnuriger, A., Dominguez, S., Valantin, M.-A., Tubiana, R., Duvivier, C., Ghosn, J., Simon, A., Katlama, C., Thibault, V. (2006). Early Detection of Hepatitis C Virus Infection by Use of a New Combined Antigen-Antibody Detection Assay: Potential Use for High-Risk Individuals. J. Clin. Microbiol. 44: 1561-1563 [Abstract] [Full Text]